Improving overall Avant! NLP technology, and updating its Machine Learning Training Models
SAN DIEGO, Feb. 28, 2023 (GLOBE NEWSWIRE) — GBT Technologies Inc. (OTC PINK: GTCH) (“GBT”, or the “Company”), is enhancing its Avant! AI technology, which is held by its partially owned subsidiary, GBT Tokenize (“Tokenize”), by equipping it with a new Natural Language Processing (NLP) systems and methods for a better user interaction experience. Additionally Tokenize is working to update Avant! training models and back-end architecture to support faster response and robust information.
Avant! -AI is a machine learning platform that learns from the Internet and constantly enhancing its information database. It relies on NLP technology to communicate with its users, and is capable of summarizing topics and obeying the rules of grammar. When Avant! works on a topic, it searches for thousands of Internet based data sources, narrowing down to only few dozen documents, and finally, concludes with the best answer to deliver.
The process is governed by sets of neural network algorithms that work cognitively to learn the topic and respond accordingly. Tokenize is currently working to enhance Avant! dialog interface, aiming more robust Q&A possibilities, combined with easier, and more friendly user interactions.
GBT Tokenize plans to further develop the system to address the needs of a new era of intelligent solutions in the fields of cybersecurity, telemedicine and autonomous machines. Avant! enhancements phase aims to be completed during the next few months, which it will be released as a new version of a web application.
“Avant! can understand unstructured data, and takes it from a wide range of sources – professional articles, research papers, blogs, and human’s input. It is trained to respond to a highly complex questions, and quickly provide an answer, backed by evidence. Since its release GBT Tokenize, which is 50% owned by GBT, used Avant! within other derivative applications.
The most recent one is Hippocrates (www.hmd.care), a first line medical advice and tips. The Hippocrates system is trained with few medical text books and CDC information and is a point of contact, intended for demonstration purposes only. Through a combination of technology and expertise, Hippocrates provides medicine-leading information, analytics, and AI solutions to assist individuals, and health professionals with medical questions, first line advice and possible treatments.
Driven by Avant! -AI machine learning technology, Hippocrates focuses on both preventative and primary care to provide first line of health-related advice and recommendations. GBT Tokenize is currently updating Avant! with enhanced NLP technology to provide robust user’s interaction experience. Additionally, it is also updating its training models and techniques to provide faster performance and enhanced informational coverage.
The field of Artificial Intelligence (AI) is growing aggressively. It’s influencing our lives and societies more than ever before and we expect that it will continue to do so at a breathtaking pace. Areas of application are diverse, the possibilities far-reaching if not limitless. Thanks to recent improvements in hardware and software, many AI algorithms surpass human experts’ capacities.
Users will be able to simply type his/hers questions in simple words, similar to interacting with another human. Avant! offers capabilities that are not off on a distant horizon. They’re far more than the fanciful dreams of sci-fi enthusiasts. The world will undoubtedly adopt more and more AI in the next decade – with greater expansion in the ensuing years.
It presents a new era of Artificial Intelligence technology that will reshape our world, enabling smart entities to work hand by hand with humans” provided Danny Rittman, the Company’s CTO.
GBT Technologies, Inc. (OTC PINK: GTCH) (“GBT”) ( https://gbtti.com ) is a development stage company which considers itself a native of Internet of Things (IoT), Artificial Intelligence (AI) and Enabled Mobile Technology Platforms used to increase IC performance.
GBT has assembled a team with extensive technology expertise and is building an intellectual property portfolio consisting of many patents. GBT’s mission, to license the technology and IP to synergetic partners in the areas of hardware and software. Once commercialized, it is GBT’s goal to have a suite of products including smart microchips, AI, encryption, Blockchain, IC design, mobile security applications, database management protocols, with tracking and supporting cloud software (without the need for GPS).
GBT envisions this system as a creation of a global mesh network using advanced nodes and super performing new generation IC technology. The core of the system will be its advanced microchip technology; technology that can be installed in any mobile or fixed device worldwide.
GBT’s vision is to produce this system as a low cost, secure, private-mesh-network between any and all enabled devices. Thus, providing shared processing, advanced mobile database management and sharing while using these enhanced mobile features as an alternative to traditional carrier services.
Certain statements contained in this press release may constitute “forward-looking statements”. Forward-looking statements provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to any historical or current fact.
Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors as disclosed in our filings with the Securities and Exchange Commission located at their website ( http://www.sec.gov ).
In addition to these factors, actual future performance, outcomes, and results may differ materially because of more general factors including (without limitation) general industry and market conditions and growth rates, economic conditions, governmental and public policy changes, the Company’s ability to raise capital on acceptable terms, if at all, the Company’s successful development of its products and the integration into its existing products and the commercial acceptance of the Company’s products.
The forward-looking statements included in this press release represent the Company’s views as of the date of this press release and these views could change. However, while the Company may elect to update these forward-looking statements at some point in the future, the Company specifically disclaims any obligation to do so.
These forward-looking statements should not be relied upon as representing the Company’s views as of any date subsequent to the date of the press release.
Dr. Danny Rittman, CTO
News Provided by GlobeNewswire via QuoteMedia